<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chlorhexidine gluconate (oral): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chlorhexidine gluconate (oral): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Chlorhexidine gluconate (oral): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="115974" href="/d/html/115974.html" rel="external">see "Chlorhexidine gluconate (oral): Drug information"</a> and <a class="drug drug_patient" data-topicid="114514" href="/d/html/114514.html" rel="external">see "Chlorhexidine gluconate (oral): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F50509913"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Paroex [DSC];</li>
<li>Peridex;</li>
<li>Periogard</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52872304"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>APO-Chlorhexidine;</li>
<li>Chlorhexidine Alcohol Free [DSC];</li>
<li>DentiCare Rinse;</li>
<li>EURO-Chlorhexidine;</li>
<li>GUM Paroex Oral Rinse;</li>
<li>Oro Clear;</li>
<li>Oro-Clense;</li>
<li>Perichlor;</li>
<li>Perichlor Without Alcohol;</li>
<li>Peridex;</li>
<li>Periogard Alcohol Free;</li>
<li>Periogard [DSC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F50510510"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic, Oral Rinse</span>;</li>
<li>
<span class="list-set-name">Antibiotic, Topical</span></li></ul></div>
<div class="block dop drugH1Div" id="F52812625"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="fbc4d2e2-03d0-4d5b-9e66-2ebc73e40b48">Gingivitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Gingivitis</b>: Limited data available: Children ≥8 years and Adolescents: Oral: Oral rinse (0.12%): Swish 15 mL (one capful) of undiluted oral rinse for 30 seconds after toothbrushing, then expectorate; repeat twice daily (morning and evening) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3164781','lexi-content-ref-28362061']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3164781','lexi-content-ref-28362061'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F52729632"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F52729633"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F50509952"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="115974" href="/d/html/115974.html" rel="external">see "Chlorhexidine gluconate (oral): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e93e521b-dcf8-4c9e-a517-ce735b97e18a">Odontogenic infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Odontogenic infection (adjunctive agent):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Acute simple gingivitis, plaque-associated: Note:</b> Use as monotherapy or, for patients with rapidly advancing disease, severe pain, or an immunocompromising condition, may use in combination with systemic antibiotics (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral rinse:</b> Swish for 30 seconds with 15 mL (one capful) of undiluted oral rinse after toothbrushing, then expectorate; repeat twice daily (morning and evening) until symptoms resolve. Use in addition to regular dental prophylaxis (cleaning).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Periodontitis, nonsevere, plaque-associated:</b>
<b>Periodontal chip:</b> Insert 1 chip into a periodontal pocket with a probing pocket depth ≥5 mm. Up to 8 chips may be inserted in a single visit. Repeat every 3 months if pocket depth remains ≥5 mm. If dislodgment occurs within 48 hours, insert a new chip. If dislodgement occurs after this time, reevaluate at 3 months; 7 days of the chip in place is considered a full course (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Manu.1'])">Ref</a></span>). Use in addition to periodontal debridement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-9776027','lexi-content-ref-17927635','lexi-content-ref-25097396','lexi-content-ref-26113100']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-9776027','lexi-content-ref-17927635','lexi-content-ref-25097396','lexi-content-ref-26113100'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="02d4b276-f517-4de4-9f18-07e25b42ddaf">Oropharyngeal decontamination</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Oropharyngeal decontamination (to reduce the risk of postoperative hospital-acquired infections) (off-label use): Note:</b> Efficacy data are conflicting; the greatest benefit may be among patients undergoing cardiac surgery (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30826096','lexi-content-ref-24663255','lexi-content-ref-17119142']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30826096','lexi-content-ref-24663255','lexi-content-ref-17119142'])">Ref</a></span>). Some experts recommend against routine use in mechanically ventilated patients not undergoing cardiac surgery (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-35589091']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-35589091'])">Ref</a></span>). Optimal dosing and regimens are uncertain; refer to institutional protocols.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Example regimen for cardiac surgical patients:</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral rinse/hygiene:</b> 15 mL swished and gargled <b>or</b> applied to intubated patients by swabbing the oral cavity (buccal, pharyngeal, gingival, tongue, and tooth surfaces) for 30 seconds 2 or 4 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-8769511','lexi-content-ref-12425407','lexi-content-ref-17119142']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-8769511','lexi-content-ref-12425407','lexi-content-ref-17119142'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990952"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50988296"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F50509934"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Toothache (51%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Upper respiratory tract infection (28%), sinusitis (14%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Gingival hyperplasia (4%), aphthous stomatitis (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Arthritis (3%), tendinopathy (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Bronchitis (6%), pharyngitis (4%)</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Cellulitis</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Dental discoloration (with oral rinse), dental discomfort, increased tartar formation, mouth discoloration</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Abscess</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Coated tongue, desquamation, dysgeusia, erythema, geographic tongue, gingivitis, glossitis, hyperkeratosis, hypersensitivity reaction, hypoesthesia, mouth irritation, oral lesion, oral mucosa ulcer, paresthesia, parotid gland enlargement, sialadenitis, stomatitis, tongue changes (short frenum), tongue edema, tongue irritation, trauma, xerostomia</p></div>
<div class="block coi drugH1Div" id="F50509931"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to chlorhexidine or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F50509932"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Serious allergic reactions, including anaphylaxis, have been reported.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Oral rinse: Staining of oral surfaces (teeth, tooth restorations, dorsum of tongue) may occur; patients exhibited a measurable increase of staining in the facial anterior after 6 months of therapy that is more pronounced when there is a heavy accumulation of unremoved plaque. Stain does not adversely affect health of the gingivae or other oral tissues, and most stain can be removed from most tooth surfaces by dental prophylaxis. Because removal may not be possible, patients with anterior facial restorations with rough surfaces or margins should be advised of the potential permanency of the stain. An increase in supragingival calculus has been observed with use; it is not known if the incidence of subgingival calculus is increased. Dental prophylaxis to remove calculus deposits should be performed at least every 6 months. May alter taste perception during use; has rarely been associated with permanent taste alteration.</p>
<p style="text-indent:-2em;margin-left:4em;">• Periodontal chip: Infectious events (eg, abscesses, cellulitis) have been observed rarely with adjunctive chip placement post scaling and root planing; use with caution in patients with periodontal disease and concomitant diseases potentially decreasing immune status (eg, diabetes, cancer). Use in acute periodontal abscess pocket is not recommended.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Oral rinse: Effect on periodontitis has not been determined; has not been tested in patients with acute necrotizing ulcerative gingivitis.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878819"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F50828726"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Mouth/Throat: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Paroex: 0.12% (473 mL [DSC]) [alcohol free; contains fd&amp;c red #40 (allura red ac dye), propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Peridex: 0.12% (118 mL, 473 mL, 1893 mL) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue), saccharin sodium; mint flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Periogard: 0.12% (473 mL [DSC]) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue), saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Periogard: 0.12% (473 mL) [alcohol free; contains fd&amp;c blue #1 (brilliant blue), polyoxyl/peg-35 castor oil(cremophor el), propylene glycol; mint flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.12% (15 mL, 118 mL, 120 mL, 473 mL)</p></div>
<div class="block geq drugH1Div" id="F50509916"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F51083812"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Chlorhexidine Gluconate Mouth/Throat)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.12% (per mL): $0.09 - $0.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Peridex Mouth/Throat)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.12% (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Periogard Mouth/Throat)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.12% (per mL): $0.02</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52872305"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Mouth/Throat: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">DentiCare Rinse: 0.12% (500 mL) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue), fd&amp;c yellow #5 (tartrazine), methylparaben, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GUM Paroex Oral Rinse: 0.12% (473 mL) [contains fd&amp;c red #40 (allura red ac dye), propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Oro Clear: 0.12% (500 mL, 4000 mL) [contains fd&amp;c blue #1 (brilliant blue), polysorbate 80, quinoline yellow (d&amp;c yellow #10), saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Perichlor: 0.12% (475 mL) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Perichlor Without Alcohol: 0.12% (475 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Peridex: 0.12% (475 mL) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue), saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Periogard: 0.12% ([DSC]) [contains alcohol, usp, fd&amp;c blue #1 (brilliant blue), polyethylene glycol (macrogol), saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Periogard Alcohol Free: 0.12% (470 mL) [contains fd&amp;c blue #1 (brilliant blue), polyoxyl/peg-35 castor oil(cremophor el), propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.12% (475 mL, 480 mL, 500 mL, 4000 mL)</p></div>
<div class="block admp drugH1Div" id="F52614663"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral rinse: Swish rinse and expectorate; do not swallow. Use in the morning and evening after brushing teeth. Following administration, do not rinse with water or other mouthwashes, brush teeth, or eat immediately.</p></div>
<div class="block adm drugH1Div" id="F50509958"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Oral rinse/hygiene: Swish rinse and expectorate after rinsing; do not swallow. Use in the morning and evening after brushing teeth. Following administration, do not immediately rinse with water or other mouthwashes, brush teeth, or eat. In mechanically ventilated patients, apply with oral applicator to buccal, pharyngeal, gingival, tongue, and tooth surfaces for 30 seconds (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-8769511']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-8769511'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Periodontal chip insertion: Pocket should be isolated and surrounding area dried prior to chip insertion. The chip should be grasped using forceps with the rounded edges away from the forceps. The chip should be inserted into the periodontal pocket to its maximum depth. It may be maneuvered into position using the tips of the forceps or a flat instrument. The chip biodegrades completely and does not need to be removed. Patients should avoid dental floss at the site of periodontal chip insertion for 10 days after placement because flossing might dislodge the chip.</p></div>
<div class="block sts drugH1Div" id="F50509946"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).</p></div>
<div class="block usep drugH1Div" id="F53571423"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Oral rinse: Treatment of gingivitis (FDA approved in adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Periodontal chip: Adjunctive therapy to reduce pocket depth in patients with periodontitis (FDA approved in adults).</p></div>
<div class="block mst drugH1Div" id="F50509909"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Peridex may be confused with Precedex</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F50509941"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F50509938"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F50509928"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events have not been observed in animal reproduction studies following use of the oral rinse; use of periodontal chip has not been studied. Chlorhexidine oral rinse is poorly absorbed from the GI tract.</p></div>
<div class="block mopp drugH1Div" id="F53571422"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Hypersensitivity reaction, dental staining, and signs and symptoms of oral irritation.</p></div>
<div class="block pha drugH1Div" id="F50509947"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Chlorhexidine has activity against gram-positive and gram-negative organisms, facultative anaerobes, aerobes, and yeast; it is both bacteriostatic and bactericidal, depending on its concentration. The bactericidal effect of chlorhexidine is a result of the binding of this cationic molecule to negatively charged bacterial cell walls and extramicrobial complexes. At low concentrations, this causes an alteration of bacterial cell osmotic equilibrium and leakage of potassium and phosphorous resulting in a bacteriostatic effect. At high concentrations of chlorhexidine, the cytoplasmic contents of the bacterial cell precipitate and result in cell death.</p></div>
<div class="block phk drugH1Div" id="F50509948"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption:</p>
<p style="text-indent:-2em;margin-left:4em;">Oral rinse: ~30% retained in the oral cavity following rinsing and slowly released into oral fluids; poorly absorbed from GI tract. After oral administration application, serum concentrations are not detectable in plasma 12 hours after dose.</p>
<p style="text-indent:-2em;margin-left:4em;">Periodontal chip: Chlorhexidine released from chip in a biphasic manner: ~40% within initial 24 hours, then remainder released linearly over 7 to 10 days; no detectable urine or plasma levels measured following insertion of 4 chips under clinical conditions</p>
<p style="text-indent:-2em;margin-left:2em;">Duration of action: Serum concentrations: Detectable levels are not present in the plasma 12 hours after administration</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Oral rinse: Feces (~90%); Urine (&lt;1%)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F50846969"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Hexon</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Hexidine</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Antiseptol | Cloradyn | Clorasept | Corsodyl | Hexidine | Oraxine | Unisept | Zordyl</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30826096">
<a name="30826096"></a>Bardia A, Blitz D, Dai F, et al. Preoperative chlorhexidine mouthwash to reduce pneumonia after cardiac surgery: a systematic review and meta-analysis. <i>J Thorac Cardiovasc Surg.</i> 2019;158(4):1094-1100. doi:10.1016/j.jtcvs.2019.01.014<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/30826096/pubmed" id="30826096" target="_blank">30826096</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19743899">
<a name="19743899"></a>Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. <i>Infect Control Hosp Epidemiol</i>. 2009;30(10):952-958.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/19743899/pubmed" id="19743899" target="_blank">19743899</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17387118">
<a name="17387118"></a>Chan EY, Ruest A, Meade MO, et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. <i>BMJ</i>. 2007; 334(7599):889. doi: 10.1136/bmj.39136.528160.BE.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/17387118/pubmed" id="17387118" target="_blank">17387118</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Chow.2019">
<a name="Chow.2019"></a>Chow AW. Complications, diagnosis, and treatment of odontogenic infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 9, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3164781">
<a name="3164781"></a>de la Rosa M, Sturzenberger OP, Moore DJ. The use of chlorhexidine in the management of gingivitis in children. <i>J Periodontol</i>. 1988;59(6):387-389.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/3164781/pubmed" id="3164781" target="_blank">3164781</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8769511">
<a name="8769511"></a>DeRiso AJ 2nd, Ladowski JS, Dillon TA, et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. <i>Chest</i>. 1996;109(6):1556-1561.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/8769511/pubmed" id="8769511" target="_blank">8769511</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21491990">
<a name="21491990"></a>Gonzales JR, Harnack L, Schmitt-Corsitto G, et al, "A Novel Approach to the Use of Subgingival Controlled-Release Chlorhexidine Delivery in Chronic Periodontitis: A Randomized Clinical Trial," <i>J Periodontol</i>, 2011;82(8):1131-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/21491990/pubmed" id="21491990" target="_blank">21491990</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12425407">
<a name="12425407"></a>Houston S, Hougland P, Anderson JJ, et al. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. <i>Am J Crit Care</i>. 2002;11(6):567-570.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/12425407/pubmed" id="12425407" target="_blank">12425407</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28362061">
<a name="28362061"></a>James P, Worthington HV, Parnell C, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. <i>Cochrane Database Syst Rev</i>. 2017;3(3):CD008676. doi:10.1002/14651858.CD008676.pub2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/28362061/pubmed" id="28362061" target="_blank">28362061</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9776027">
<a name="9776027"></a>Jeffcoat MK, Bray KS, Ciancio SG, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. <i>J Periodontol</i>. 1998;69(9):989-997. doi:10.1902/jop.1998.69.9.989<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/9776027/pubmed" id="9776027" target="_blank">9776027</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17927635">
<a name="17927635"></a>Kasaj A, Chiriachide A, Willershausen B. The adjunctive use of a controlled-release chlorhexidine chip following treatment with a new ultrasonic device in supportive periodontal therapy: a prospective, controlled clinical study. <i>Int J Dent Hyg</i>. 2007;5(4):225-231. doi:10.1111/j.1601-5037.2007.00255.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/17927635/pubmed" id="17927635" target="_blank">17927635</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35589091">
<a name="35589091"></a>Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. <i>Infect Control Hosp Epidemiol</i>. 2022;43(6):687-713. doi:10.1017/ice.2022.88<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/35589091/pubmed" id="35589091" target="_blank">35589091</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24663255">
<a name="24663255"></a>Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. <i>JAMA Intern Med</i>. 2014;174(5):751-761. doi:10.1001/jamainternmed.2014.359<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/24663255/pubmed" id="24663255" target="_blank">24663255</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25097396">
<a name="25097396"></a>Kumar AJ, Ramesh Reddy BV, Chava VK. Effect of chlorhexidine chip in the treatment of chronic periodontitis. <i>J Nat Sci Biol Med</i>. 2014;5(2):268-272. doi:10.4103/0976-9668.136159<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/25097396/pubmed" id="25097396" target="_blank">25097396</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21798809">
<a name="21798809"></a>Labeau SO, Van de Vyver K, Brusselaers N, et al. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. <i>Lancet Infect Dis</i>. 2011;11(11):845-854. doi: 10.1016/S1473-3099(11)70127-X.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/21798809/pubmed" id="21798809" target="_blank">21798809</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24106323">
<a name="24106323"></a>Nicolosi LN, del Carmen Rubio M, Martinez CD, González NN, Cruz ME. Effect of oral hygiene and 0.12% chlorhexidine gluconate oral rinse in preventing ventilator-associated pneumonia after cardiovascular surgery. <i>Respir Care.</i> 2014;59(4):504-509. doi:10.4187/respcare.02666<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/24106323/pubmed" id="24106323" target="_blank">24106323</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Nupro (chlorhexidine gluconate) [prescribing information]. York, PA: Dentsply Professional; October 2017.</div>
</li>
<li>
<div class="reference">
                  Nupro (chlorhexidine gluconate) [prescribing information]. St. Paul, MN: 3M ESPE Dental Products; October 2015.</div>
</li>
<li>
<div class="reference">
                  Paroex (chlorhexidine gluconate) [prescribing information]. Worcester, MA: Lohxa; received March 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Peridex.1">
<a name="Peridex.1"></a>Peridex (chlorhexidine gluconate) [prescribing information]. St. Paul, MN: 3M ESPE Dental Products; August 2022.</div>
</li>
<li>
<div class="reference">
                  Peridex (chlorhexidine gluconate) [prescribing information]. London, Ontario, Canada: 3M Canada Dental Products; June 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-PerioChip.1">
<a name="PerioChip.1"></a>PerioChip (chlorhexidine gluconate) [prescribing information]. Yokneam, Israel: Dexcel Pharma Technologies Ltd; May 2021.</div>
</li>
<li>
<div class="reference">
                  PerioGard (chlorhexidine gluconate) [prescribing information]. New York, NY: Colgate Oral Pharmaceuticals, Inc; December 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12747444">
<a name="12747444"></a>Reddy MS, Jeffcoat MK, Geurs NC, et al, “Efficacy of Controlled-Release Subgingival Chlorhexidine to Enhance Periodontal Regeneration,” <i>J Periodontol</i>, 2003, 74(4):411-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/12747444/pubmed" id="12747444" target="_blank">12747444</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35300956">
<a name="35300956"></a>Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. <i>J Oral Maxillofac Surg</i>. 2022;80(5):920-943. doi:10.1016/j.joms.2022.02.008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/35300956/pubmed" id="35300956" target="_blank">35300956</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19765321">
<a name="19765321"></a>Scannapieco FA, Yu J, Raghavendran K, et al. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. <i>Crit Care</i>. 2009;13(4):R117. doi: 10.1186/cc7967.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/19765321/pubmed" id="19765321" target="_blank">19765321</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17119142">
<a name="17119142"></a>Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. <i>JAMA</i>. 2006;296(20):2460-2466. doi:10.1001/jama.296.20.2460<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/17119142/pubmed" id="17119142" target="_blank">17119142</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26113100">
<a name="26113100"></a>Smiley CJ, Tracy SL, Abt E, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. <i>J Am Dent Assoc</i>. 2015;146(7):525-535. doi:10.1016/j.adaj.2015.01.026<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/26113100/pubmed" id="26113100" target="_blank">26113100</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12747445">
<a name="12747445"></a>Soskolne WA, Proskin HM, and Stabholz A, “Probing Depth Changes Following 2 Years of Periodontal Maintenance Therapy Including Adjunctive Controlled Release of Chlorhexidine,” <i>J Periodontol</i>, 2003, 74(4):420-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/12747445/pubmed" id="12747445" target="_blank">12747445</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Yong D, Parker FC, and Foran SM, “Severe Allergic Reactions and Intra-Urethral Chlorhexidine Gluconate,” <i>Med J Aust</i>, 1995, 162(5):257-8.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-pediatric-drug-information/abstract-text/ 7891607 /pubmed" id=" 7891607 " target="_blank"> 7891607 </a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 115976 Version 195.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
